INTRODUCTION
============

Prevalence rate of obesity has increased since 1988. Particularly, it was 42.3% among males in South Korea in 2016.[@b1-jomes-28-105] Obesity is a significant risk factor for many serious illnesses such as gastrointestinal cancer, heart disease, stroke and diabetes.[@b2-jomes-28-105]--[@b5-jomes-28-105] Increased physical activity, diet modification, drugs, and surgery are common strategies to treat obesity.[@b6-jomes-28-105] Currently available anti-obesity drugs are associated with several adverse effects such as hyperthyroidism, palpitations, anxiety, insomnia, and diarrhea.[@b7-jomes-28-105] Therefore, there is a growing demand for the development of new and safe anti-obesity agents.

Imbalance between energy intake and its consumption can lead to an excessive accumulation of lipids in the adipose tissue. Adipose tissue is a key regulator of energy balance, playing an active role in lipid storage and buffering, synthesizing, and secreting a wide range of endocrine products into blood circulation that influence systemic metabolism.[@b8-jomes-28-105] Therefore, inhibition of adipogenesis in adipocytes could be a good strategy to prevent and treat obesity.

*Ainsliaea acerifolia* is a perennial plant, which belongs to the family Compositae and has been used in folk medicine for the treatment of rheumatoid arthritis and enteritis.[@b9-jomes-28-105] It has been reported that zaluzanin C, a sesquiterpene lactone mainly isolated from family Compositae, exhibits anti-fungal, anti-inflammatory and anti-cancer activities, and osteoblastic differentiation potential.[@b10-jomes-28-105]--[@b17-jomes-28-105] However, its effect on differentiation of 3T3-L1 preadipocytes remains uncertain. Therefore, this study aimed to investigate whether zaluzanin C affects the differentiation of 3T3-L1 preadipocytes into mature adipocytes.

METHODS
=======

Reagents
--------

For cell culture, bovine calf serum (BCS), fetal bovine serum (FBS), penicillin, streptomycin, Dulbecco's modified Eagle's medium (DMEM) and 0.5% Trypsin-ethylenediaminetetraacetic acid (EDTA) were purchased from Hyclone (Logan, UT, USA). Methylisobutylxanthine (IBMX), dexamethasone, insulin, and Oil red O solution were obtained from Sigma-Aldrich (St. Louis, MO, USA). Sodium pyruvate was purchased from Gibco Invitrogen (Carlsbad, CA, USA). Formaldehyde solution was obtained from Junsei chemical (Tokyo, Japan). For protein estimation, Bio-Rad Protein Assay kit was purchased from Bio-Rad Laboratories (Hercules, CA, USA). Anti-aP2/fatty acid binding protein 4 (FABP4) rabbit polyclonal (\#2120) and anti-CCAAT/enhancer binding protein alpha (C/EBPα; D56F10, \#8178) antibodies were procured from Cell Signaling Technology (Danvers, MA, USA), and anti-peroxisome proliferator-activated receptor gamma (PPARγ; E-8, \#sc-7273) and anti-β-actin mouse monoclonal antibodies were purchased from Santa Cruz Biotechnology (Dallas, TX, USA) and Novus Biologicals (Littleton, CO, USA), respectively.

Isolation of zaluzanin C
------------------------

Zaluzanin C was extracted and isolated from *Ainsliaea acerifolia* using a method developed by Lee et al.[@b18-jomes-28-105] *A. acerifolia* was purchased from Yeongyang-gun, Gyeongsangbuk-do, Korea in May 2013. *A. acerifolia* (5.0 kg) was extracted with 70% ethanol (EtOH) at room temperature and the solvent was evaporated in vacuo. The crude EtOH extract was suspended in distilled water (DW), and then partitioned in turn with *n*-hexane, ethyl acetate (EtOAc) and *n*-butyl alcohol (*n*-BuOH) to yield after concentration dried *n*-hexane (73.8 g), EtOAc (56.0 g), *n*-BuOH (27.9 g) and H~2~O-soluble (186.0 g) residues. A portion (20.0 g) of the EtOAC-soluble fraction was chromatographed over a Toyopearl HW 40 (coarse grade; 1.5 cm×51 cm) with H~2~O containing increased amounts of methanol (MeOH) in a stepwise gradient mode. The H~2~O eluate was subjected to a combination of chromatography over YMC gel ODS AQ 120S column (1.1 cm×40 cm) with aqueous MeOH to yield pure zaluzanin C (188.4 mg).

Cell line and culture
---------------------

3T3-L1 mouse embryonic fibroblast cell line is derived from 3T3 cells and is widely used in biological research on adipose tissue.[@b19-jomes-28-105] 3T3-L1 cell line was obtained from the Korean Cell Bank (Seoul, Korea), and was grown in DMEM supplemented with 10% BCS, 100 U/mL penicillin and 100 μg/mL streptomycin. Cells were maintained at 37°C in a humidified incubator with 5% CO~2~.

Cell differentiation
--------------------

For the induction of adipocyte differentiation, 3T3-L1 preadipocytes were seeded at a density of 5×10^4^ cells/mL/well in a 24-well plate. As shown in [Fig. 1](#f1-jomes-28-105){ref-type="fig"}, at confluence (day 0), the cultured preadipocytes were induced to differentiate by the addition of differentiating medium (DMEM containing 115 μg/mL IBMX, 10 μg/mL insulin, and 1 μM dexamethasone) from day 0 to day 6. At day 6, medium was changed with medium containing 10 μg/mL insulin for an additional 6 days from day 6 to day 12. The medium was refreshed every 3 days. At day 12, differentiated 3T3-L1 cells were subjected to Oil red O solution or used for Western blot analysis. Zaluzanin C was dissolved in dimethyl sulfoxide (DMSO) and was added to the cell culture medium at concentrations of 0, 1, 2.5, 5, and 10 μM from day 0 to day 12 ([Fig. 1](#f1-jomes-28-105){ref-type="fig"}). Light microscopy and Oil red O staining were used to monitor the characteristic cell rounding and lipid accumulation during the cell differentiation, respectively.

Oil red O staining
------------------

After cell differentiation, cells were fixed with 1 mL of 10% formaldehyde solution for 1 hour. Fixed cells were washed with 2 mL of 60% isopropyl alcohol and were air dried. One milliliter of Oil red O solution was added to each well and the each well was incubated for 10 minutes. After the removal of Oil red O solution, cells were washed four times with DW and imaged. Accumulated intracellular Oil red O dye was completely extracted by 1 mL of 100% isopropyl alcohol and quantified by measuring its absorbance at 490 nm (Sunrise Tecan, Grödig, Austria).

Cell proliferation and cytotoxicity assay
-----------------------------------------

The cytotoxicity of zaluzanin C and its effect on cell proliferation was determined using CytoTox96 Non-Radioactive Cytotoxicity Assay (Promega, Madison, WI, USA) and CellTiter96 Aqueous One Solution Assay of cell proliferation (Promega), respectively. 3T3-L1 preadipocytes were seeded at a density of 1×10^4^ cells/200 μL/well in a 96 well plate, and zaluzanin C was added to each well at a concentration range of 0--10 μM in DMEM containing 1% FBS. After 48-hour incubation, cytotoxicity and cell proliferation were measured according to the manufacturer's instructions. In 0 μM zaluzanin C group, cells were treated with an equal volume of DMSO, maintained at maximum concentration of not more than 0.001% v/v.

Preparation of whole cell lysates
---------------------------------

To prepare whole cell lysate, cells were lysed in lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 50 mM sodium fluoride (NaF), 30 mM sodium pyrophosphate (Na~4~P~2~O~7~), 1 mM phenylmethanesulfonyl fluoride, 2 mg/mL aprotinin, and 1 mM pervanadate. The lysates were clarified by centrifugation at 12,000×*g* for 15 minutes at 4°C. The lysates were stored at −80°C until needed.

Western blotting analysis
-------------------------

Proteins in whole cell lysates were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and were transferred to Immobilon transfer membranes with pore size of 0.45 μm (Millipore, Billerica, MA, USA). After blocking with 1×blocking buffer (Biofact Biofactory, Daejeon, Korea) for 1 hour, membranes were incubated with the primary antibody at 4°C overnight. Membranes were then washed with Tris buffered saline-Tween 20 solution and were incubated with anti-rabbit or anti-mouse immunoglobulin G conjugated to horseradish peroxidase for 1 hour. After washing, the protein bands were then visualized using enhanced chemiluminescence reagent (Thermo Fisher Scientific Inc., Pittsburgh, PA, USA) and LAS-3000 Lumino Image Analyzer System (Fujifilm, Tokyo, Japan). Densitometric measurements of band intensities were performed using Image J free software (NIH, Bethesda, MA, USA).

Statistical analysis
--------------------

GraphPad Prism version 5.0 software (GraphPad, San Diego, CA, USA) was used for statistical analysis. The data were expressed as the mean±standard error of the mean of three independent experiments. Differences between the mean values of multiple groups were analyzed using one-way analysis of variance with Dunnett test or Tukey's test. A *P*\<0.05 was considered as statistically significant.

RESULTS
=======

As part of our ongoing screening program, antiadipogenic potentials of 11 types of bioactive compounds were evaluated.[@b20-jomes-28-105] According to Kwak's study[@b20-jomes-28-105], 10 μM zaluzanin C inhibited lipid accumulation, a characteristic of differentiated adipocytes[@b21-jomes-28-105],[@b22-jomes-28-105], in 3T3-L1 adipocytes. Based on this result, antiadipogenic potential of zaluzanin C and its underlying mechanism was evaluated in the subsequent experiments.

As 10 μM zaluzanin C was shown to inhibit lipid accumulation in 3T3-L1 adipocytes, its effect was examined on cell proliferation and cytotoxicity in 3T3-L1 preadipocytes. Since zaluzanin C did not inhibit cell proliferation and showed no cytotoxicity up to 10 μM concentration ([Fig. 2](#f2-jomes-28-105){ref-type="fig"}), it was indicated that its inhibitory effect against lipid accumulation was not related to its cytotoxicity or anti-proliferative effect. Therefore, zaluzanin C was used at a concentration range of 0--10 μM for the subsequent experiments.

To evaluate the effect of zaluzanin C on lipid accumulation during adipogenesis of 3T3-L1 preadipocytes, intracellular lipid content was measured at day 12 using Oil red O staining. The absorbance value of the negative control was 0.04 and that of 0 μM zaluzanin C was 0.14 ([Fig. 3](#f3-jomes-28-105){ref-type="fig"}). Differentiation medium induced an increase in absorbance up to 350% in cells treated with 0 μM zaluzanin C compared to the negative control group ([Fig. 3](#f3-jomes-28-105){ref-type="fig"}).

An understanding of the process of adipose formation and the mechanisms that govern adipogenesis is vital in the fight against the growing incidence of obesity.[@b23-jomes-28-105] Therefore, attenuation of the expression of adipogenic related transcription factors, such as PPARγ and C/EBPα by zaluzanin C was evaluated using Western blot analysis. At day 12, PPARγ expression was significantly increased in 0 μM zaluzanin group compared to the negative control group ([Fig. 4](#f4-jomes-28-105){ref-type="fig"}). Zaluzanin C effectively inhibited the differentiation medium-induced increase of PPARγ expression in 3T3-L1 adipocytes at concentrations greater than 1 μM. Then, expression of FABP4 protein was determined by Western blot analysis. Similarly, expression of FABP4 was decreased by treatment with zaluzanin C, significantly at 10 μM concentration compared to 0 μM zaluzanin C group. Also C/EBPα protein expression was significantly induced in 0 μM zaluzanin C group compared to negative control cells. However, zaluzanin C did not inhibit expression of C/EBPα.

DISCUSSION
==========

Recently, many studies have been conducted in order to find natural bioactive agents which have antiadipogenic effect in 3T3-L1 preadipocytes.[@b6-jomes-28-105],[@b7-jomes-28-105],[@b23-jomes-28-105],[@b24-jomes-28-105] Immortalized murine cell lines such as 3T3-L1 preadipocytes are capable of differentiating into mature white adipocytes under appropriate hormonal balance, in presence of FBS, dexamethasone, IBMX, and insulin.[@b22-jomes-28-105],[@b25-jomes-28-105] Since 3T3-L1 preadipocyte cell line as an *in vitro* model of adipogenesis has been proven to be an invaluable resource in elucidating mechanisms of adipocyte differentiation[@b25-jomes-28-105], these cells were used to investigate the effects of zaluzanin C on adipogenesis. From results of [Fig. 3](#f3-jomes-28-105){ref-type="fig"}, they indicate that 3T3-L1 preadipocytes differentiate well into mature adipocytes by treatment with differentiation medium. However, treatment with ≥1 μM zaluzanin C inhibited lipid accumulation in 3T3-L1 adipocytes. These results suggest that zaluzanin C has an antiadipogenic effect.

Adipogenesis is the process by which precursor stem cell differentiate into lipid laden adipocytes.[@b21-jomes-28-105] This process is regulated by transcriptional activators such as PPARγ and C/EBPα.[@b25-jomes-28-105],[@b26-jomes-28-105] These transcription factors were known to regulate the middle and late stages of adipocyte differentiation.[@b27-jomes-28-105] Also, FABP4 is a differentiated adipocyte marker gene that is transcriptionally regulated by PPARγ.[@b28-jomes-28-105],[@b29-jomes-28-105] Although C/EBPα is an important factor in terminal differentiation of adipocytes, knockout of C/EBPα in adipocytes did not show insulin sensitivity.[@b30-jomes-28-105],[@b31-jomes-28-105] It means that C/EBPα is an essential factor in which adipocyte acquires insulin sensitivity. As obesity and insulin resistance are strongly linked to the accumulation of excessive lipids[@b32-jomes-28-105], maintenance of C/EBPα by treatment of zaluzanin C has significant meaning in improving insulin resistance that occur by excess lipid accumulation. PPARγ is capable of promoting adipogenesis in C/EBPα-deficient cells, whereas C/EBPα is incapable of promoting adipogenesis in PPARγ-deficient cells. These findings demonstrate that PPARγ is a more important master regulator of adipogenesis than C/EBPα.[@b30-jomes-28-105]

This is the first study to demonstrate that zaluzanin C inhibits differentiation of preadipocytes to mature adipocytes. These data suggest that zaluzanin C particularly affects PPARγ, a key transcription factor for adipogenesis, and does not inhibit the process which acquires insulin sensitivity. Although this study does not reveal how zaluzanin C selectively regulate expression of PPARγ and C/EBPα, previous studies have demonstrated that zaluzanin C exhibited the most potent inhibitory effect in advanced glycation end products, which is valuable therapeutic targets for the regulation of diabetic complications.[@b33-jomes-28-105] Also, zaluzanin C inhibited α-glucosidase activity which is one of the targets for treatment of diabetes.[@b18-jomes-28-105] As C/EBPα is an essential factor in which adipocytes acquire insulin sensitivity, maintenance of C/EBPα by treatment of zaluzanin C could positively affect improvement of obesity related diabetes. However, further study is needed to evaluate molecular mechanisms on how zaluzanin C increase expression of C/EBPα. In conclusion, zaluzanin C may be a potential source for the treatment of obesity.
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![Experimental scheme. For the induction of adipocyte differentiation, 3T3-L1 preadipocytes were seeded. At confluence (day 0), the cultured preadipocytes were induced to differentiate by the addition of differentiating medium containing 115 μg/mL methylisobutylxanthine (IBMX), 10 μg/mL insulin, and 1 μM dexamethasone (Dex) from day 0 to day 6. At day 6, medium was changed with medium containing 10 μg/mL insulin for an additional 6 days from day 6 to day 12. The medium was refreshed every 3 days. At day 12, differentiated 3T3-L1 cells were subjected to Oil red O solution or used for Western blot analysis. Zaluzanin C was added to the cell culture medium at concentrations of 0, 1, 2.5, 5, and 10 μM from day 0 to day 12. DMEM, Dulbecco's modified Eagle's medium.](jomes-28-105f1){#f1-jomes-28-105}

![Effect of zaluzanin C on cell proliferation and cytotoxicity in 3T3-L1 preadipocyte. 3T3-L1 cells were seeded in a 96 well plate and treated with various concentrations of zaluzanin C (0, 1, 2.5, 5, and 10 μM). After 48 hours, cell proliferation (A) and cytotoxicity (B) were determined using CytoTox 96 non-radioactive cytotoxicity assay and CellTiter 96 Aqueous One Solution assay. The results are presented as mean±standard error of the mean of three independent experiments (n=3). \*^,†^Indicate statistically significant differences between groups.](jomes-28-105f2){#f2-jomes-28-105}

![Effect of zaluzanin C on lipid accumulation in 3T3-L1 cells. 3T3-L1 cells were treated with differentiation medium in the absence or presence of different concentrations of zaluzanin C (0, 1, 2.5, 5, and 10 μM) for 12 days. (A) On day 12, 3T3-L1 cells were stained with Oil-red O solution and took a photograph. (B) Lipid accumulation was then assessed by extracting Oil-red O from stained 3T3-L1 cells. The results are presented as mean±standard error of the mean of three independent experiments (n=3). \*^,†,‡^Indicate statistically significant differences between groups.](jomes-28-105f3){#f3-jomes-28-105}

![Effect of zaluzanin C on the expression of peroxisome proliferator-activated receptor gamma (PPARγ), fatty acid binding protein 4 (FABP4) and CCAAT/enhancer binding protein alpha (C/EBPα) in 3T3-L1 cells. 3T3-L1 cells were treated with differentiation medium in the absence or presence of different concentrations of zaluzanin C (0, 1, 2.5, 5, 10 μM) for 12 days. From each whole cell lysate, 10 μg of proteins was resolved by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis for determination of FABP4, PPARγ and C/EBPα expression. β-actin expression is shown as a loading control. The bands (A) were quantified using image analysis software, and their relative intensities of PPARγ (B), FABP4 (C), or C/EBPα (D) were expressed as target protein/β-actin. The results are presented as mean±standard error of the mean of three independent experiments (n=3). \*^,†,‡^Indicate statistically significant differences between groups.](jomes-28-105f4){#f4-jomes-28-105}
